The U.S. should assess the economic value of drugs rather than leave it up to other countries

Stat News

17 January 2019 - One reason why prescription drugs are often priced lower overseas is that many countries perform detailed assessments of the economic value of drugs and their benefits. 

These assessments result in hard bargaining with drug companies before the medicines are allowed into national health plans.

The Trump administration has proposed to reference prices set through drug valuations made by other countries as a way to help Medicare contain prices for drugs administered in U.S. doctors’ offices and hospitals (Medicare Part B).

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder